Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Subcutaneous Orencia available for patients 2 years of age and older

June 9, 2017

Bristol-Myers Squibb patents TYK2 inhibitors

June 8, 2017

BAMBI inhibition is beneficial in autoimmune diseases

May 31, 2017

FDA approves Kevzara for rheumatoid arthritis

May 23, 2017

Emmyon patents new furostan-3-ol derivatives

May 23, 2017

ALX-1141 to enter clinical development for the treatment of osteoarthritis

May 23, 2017

Articular cartilage product granted positive opinion from CHMP for European approval

May 22, 2017

EMA accepts for review MAA for adalimumab biosimilar, FKB-327

May 22, 2017

Symic reports topline results from phase I/IIa study of SB-061 for osteoarthritis of the knee

May 19, 2017

Development of cell-mediated gene therapy Invossa updated at ASCGT

May 16, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...